Large‐scale survey for potentially targetable indels in bacterial and protozoan proteins
- 28 November 2005
- journal article
- research article
- Published by Wiley in Proteins-Structure Function and Bioinformatics
- Vol. 62 (2) , 371-380
- https://doi.org/10.1002/prot.20631
Abstract
Our previous results demonstrated that some essential, housekeeping proteins from pathogenic microorganisms may contain sizable insertions–deletions in their sequences (compared to close human homologs) that can be responsible for unexpected virulence properties. For example, we found that indel‐bearing elongation factor‐1α from several pathogenic protozoa can activate a human tyrosine phosphatase SHP‐1 leading to deactivation of macrophages. On the one hand, these findings allowed development of a strategy for targeting some indel‐containing pathogen proteins that have similar human counterparts. On the other hand, the results raised numerous questions regarding the nature and implications of sequence indels in pathogen proteins. In the present study, we conducted a large‐scale survey of indels in proteins from 136 bacterial and protozoan genomes. It has been established that sizable insertions and deletions occur in approximately 5–10% of bacterial proteins with close human homologs, while proteins from the protozoan pathogens such as Trypanosoma cruzi, Plasmodium falciparum, and Leishmania donovani exhibit elevated indel content that can reach up to 25%. The finding suggested that the occurrence of sequence indels may be involved in the evolution of pathogenic mechanisms in these protozoa. Proteins 2006.Keywords
This publication has 26 references indexed in Scilit:
- Bacterial Genomes and Infectious DiseasesPediatric Research, 2003
- Bacterial GenomicsBioDrugs, 2002
- Bacterial virulence as a target for antimicrobial chemotherapyCurrent Opinion in Biotechnology, 2000
- DNA Helicases, Genomic Instability, and Human Genetic DiseaseAnnual Review of Genomics and Human Genetics, 2000
- From genes to sequences to antibiotics: prospects for future developments from microbial genomicsMicrobes and Infection, 2000
- Searching for drug targets in microbial genomesCurrent Opinion in Biotechnology, 1999
- New antibiotic discovery, novel screens, novel targets and impact of microbial genomicsCurrent Opinion in Microbiology, 1998
- Novel approaches to the discovery of antimicrobial agentsCurrent Opinion in Chemical Biology, 1998
- Innovative approaches to novel antibacterial drug discoveryCurrent Opinion in Biotechnology, 1997
- Microbial pathogen genomes — new strategies for identifying therapeutics and vaccine targetsTrends in Biotechnology, 1996